Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ai‐chun Liu"'
Autor:
Ping Yang, Qing‐qing Cai, Wei Zhang, Shuo‐zi Liu, Hui Liu, Xiu‐hua Sun, Yu‐jun Dong, Xiu‐bin Xiao, Jing‐wen Wang, Zhen‐ling Li, Wen‐rong Huang, Li‐hong Li, Hui‐zheng Bao, Wei Yang, Ya‐lan Wang, Shu‐ye Wang, Juan He, Xiao‐ling Li, Ai‐chun Liu, Hong‐mei Jing
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13204-13216 (2023)
Abstract Background Mantle cell lymphoma (MCL) is an uncommon heterogeneous subtype of B cell non‐Hodgkin lymphoma, and clinical features in MCL appear regional characteristics. MCL treatment opinions are not uniform between countries or regions wi
Externí odkaz:
https://doaj.org/article/ac2dfccadb9c4155b0735bebbad177b8
Autor:
Yuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, Wei Xu, Hui-Qiang Huang, Xiu-Bin Xiao, Jun Zhu, Dao-Bin Zhou, Xiao-Hong Han, Jian-Qiu Wu, Ming-Zhi Zhang, Jie Jin, Xiao-Yan Ke, Wei Li, De-Pei Wu, Shen-Miao Yang, Xin Du, Yong-Qian Jia, Ai-Chun Liu, Dai-Hong Liu, Zhi-Xiang Shen, Lian-Sheng Zhang, Leonard James, Edward Hellriegel, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 11, Pp 1299-1309 (2021)
Abstract. Background:. Bendamustine was approved in China on May 26th, 2019 by the National Medical Product Administration for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL). The current study was the registration trial and the first rep
Externí odkaz:
https://doaj.org/article/2e136575615e46fc9bd3c8c49fd5d2b5
Autor:
Dong-Wei Fu, Ai-Chun Liu
Publikováno v:
Cancer Management and Research
Dong-Wei Fu, Ai-Chun Liu Department of Hematology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, People’s Republic of ChinaCorrespondence: Ai-Chun LiuDepartment of Hematology, Harbin Medical University, Cancer Hospital, Ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc157aa9ac839aa7b58bd327e566d15c
https://doi.org/10.2147/cmar.s284258
https://doi.org/10.2147/cmar.s284258
Autor:
Ping Yang, Qing‐qing Cai, Wei Zhang, Shuo‐zi Liu, Hui Liu, Xiu‐hua Sun, Yu‐jun Dong, Xiu‐bin Xiao, Jing‐wen Wang, Zhen‐ling Li, Wen‐rong Huang, Li‐hong Li, Hui‐zheng Bao, Wei Yang, Ya‐lan Wang, Shu‐ye Wang, Juan He, Xiao‐ling Li, Ai‐chun Liu, Hong‐mei Jing
In this study, we aimed to investigate treatment options and the prognosis of patients with mantle cell lymphoma in China. 805 patients diagnosed with MCL between April 1999 and December 2019 at 19 comprehensive hospitals in China were included in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09933e764281e011b9dd7677923bd488
https://doi.org/10.21203/rs.3.rs-1516468/v1
https://doi.org/10.21203/rs.3.rs-1516468/v1
Autor:
Li Jiang, Jiang Hong Sun, Li-Na Quan, Yu-Yang Tian, Chui-Ming Jia, Zhi-Qiang Liu, Ai-Chun Liu, Jiang, Li, Sun, Jiang Hong, Quan, Li-Na, Tian, Yu-Yang, Jia, Chui-Ming, Liu, Zhi-Qiang, Liu, Ai-Chun
Publikováno v:
Journal of Cancer Research & Therapeutics; Apr-Jun2016, Vol. 12 Issue 2, p605-611, 7p